Nitric Oxide in Pulmonary Hypertension
Description: PROJECT NARRATIVE Pulmonary arterial hypertension (PAH) is a progressive and often lethal disease that disproportionately affects women. In this project, our goal is to discover the cellular metabolic mechanisms underlying the development and progression of PAH so that we can develop new strategies for treatment of patients.
Funding type: research
Funder scheme: R01
Start date: 1999-04-01
End date: 2025-12-31
Investigator: SERPIL C. ERZURUM
Institution: CLEVELAND CLINIC LERNER COM-CWRU
Funded outputs count: 91
Funder award ID: R01HL060917
OpenAlex ID: G7166330850
